Kane Biotech, Inc. (KNE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NexgenRx, Inc.

Everyday People Financial Corp.

Willow Biosciences, Inc.

American Aires, Inc.

TDG Gold Corp.

Personas Social, Inc.

Kane Biotech, Inc.

RevoluGROUP Canada, Inc.

ASEP Medical Holdings, Inc.

SOL Global Investments Corp.

NextGen Food Robotics Corp.

Why is Kane Biotech, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Kane Biotech, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Kane Biotech, Inc.

-70.0%

-0.55

125.53%

S&P/TSX 60

21.87%

1.55

15.31%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-18.34%

EBIT Growth (5y)

5.15%

EBIT to Interest (avg)

-4.63

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.75

Sales to Capital Employed (avg)

-0.15

Tax Ratio

31.23%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-6.36

EV to EBIT

-2.39

EV to EBITDA

-2.54

EV to Capital Employed

7.72

EV to Sales

7.72

PEG Ratio

Dividend Yield

ROCE (Latest)

-323.40%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at CAD -0.96 MM

-9What is not working for the Company

NET SALES(HY)

At CAD 0.04 MM has Grown at -98.08%

RAW MATERIAL COST(Y)

Grown by 1,351.93% (YoY

Here's what is working for Kane Biotech, Inc.

Net Profit

Higher at CAD -0.96 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Here's what is not working for Kane Biotech, Inc.

Net Sales

At CAD 0.04 MM has Grown at -98.08%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CAD MM)

Raw Material Cost

Grown by 1,351.93% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales